t:slim Mobile Application, iOS 1014707
Ref 1014707
t:slim Mobile Application, iOS 1014707 is an ambulatory insulin infusion pump (EU MDR Class III; FDA Class II; FDA product code QFG, Alternate Controller Enabled Insulin Infusion Pump) made by Tandem Diabetes Care, Inc., registered in EUDAMED on 21 Apr 2026 (Basic UDI-DI 0850018992TF-0011603KR) with CE/MDR certificate MDR 824766 valid until 14 May 2030, cleared under FDA 510(k) K232380 on 3 Nov 2023 and listed in FDA GUDID since 14 Mar 2025 (UDI-DI 00389152470740), active as of 24 Oct 2026. 4 FDA recalls are linked to it.
Active
Valid until
14 May 2030
FDA recalls
4 ongoingTrust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR EUDAMED | NumberMDR 824766 | Date2 Sep 2026 | StatusActive |
| United States | GUDID listing GUDID | Number00389152470740 | Date14 Mar 2025 | StatusListed |
| United States | FDA 510(k)SESE GUDID | NumberK232380 | Date3 Nov 2023 | StatusActive |
Official records
- EUDAMED public site 0850018992TF-0011603KR
- AccessGUDID record 00389152470740
- FDA 510(k) database K232380
From the FDA record
- Device description
- Tandem t:slim Mobile Application, iOS version 2.9
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI 0850018992TF-0011603KR registered 21 Apr 2026 Active
- FDA 510(k) K232380 decided 3 Nov 2023 Active
- FDA GUDID UDI-DI 00389152470740 listed 14 Mar 2025 Listed
Certificates
- MDR 824766 Active
Technical documentation EU MDR
- Certifier
- BSI Group The Netherlands B.V. 2797
- Issued
- 2 Sep 2026
- Expires
- 14 May 2030
- Reason
- Change approved
Recalls
-
- Ongoing Z-3330-2026
A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P users to use their t:slim insulin pumps in manual mode. FSL3P users are unable to access their CGM's glucose values from within the t:slim app and cannot use their pumps in automated control (closed-loop) mode, which could lead to users experiencing hypoglycemia or hyperglycemia.
-
- Ongoing Z-1636-2026
The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Following this instruction could result in unintended insulin delivery, potentially leading to a hypoglycemic event.
-
- Ongoing Z-2621-2025
an app defect that occurs when the phone is set to a right-to-left language, which causes app-pump pairing issues and graphical defects, which can potentially lead to incorrect therapy decisions and subsequent hypoglycemia or hyperglycemia.
-
- Ongoing Z-1519-2025
A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.
Timeline
- Cleared FDA 510(k) K232380
- Recall initiated FDA recalls Z-1519-2025
- Listed FDA GUDID 00389152470740
- Recall initiated FDA recalls Z-2621-2025
- Recall initiated FDA recalls Z-1636-2026
- Registered EUDAMED 0850018992TF-0011603KR
- Recall initiated FDA recalls Z-3330-2026
- Certificate issued EUDAMED MDR 824766
- Certificate expires EUDAMED MDR 824766
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Tandem t:slim Mobile App EUDAMEDt:slim Mobile Application, iOS GUDID
- Generic name
- Ambulatory insulin infusion pump, electronic, software-dosing, scalar algorithm
- Device name
- Tandem Mobile Application
- Model / reference
- 1014707
- Primary DI / UDI-DI
- 00389152470740
- Basic UDI-DI
- 0850018992TF-0011603KR
- Direct marketing DI
- 00389152470740
- 510(k) Number
- FDA product code
- QFG
- EMDN code
- Z12030382 Infusion instruments - software accessories
- GMDN term
- Ambulatory insulin infusion pump, electronic, software-dosing, scalar algorithm
- Device class
- Class III EUDAMEDClass II GUDID
- Regulation number
- 880.5730
- Special device type
- Software
- EU registration type
- Standard device
- EU market of registration
- Czechia
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class III | Class II |
Similar devices in this category
Other devices filed under INFUSION INSTRUMENTS.
- DOSE IQ SAFETY SOFTWARE DOSEIQW0001 by Baxter Healthcare SA
- Infusion Pump BeneFusion iVP by Shenzhen Mindray Scientific Co., Ltd.
- Infusion Pump Sunfusion Anim-8 by Hunan Beyond Medical Technology Co., Ltd.
- basixCOMPAK™ 00884450535257 by Merit Medical Systems, Inc.
- Infusion Pump VP50 Pro by Shenzhen MedRena Biotech Co., Ltd.
- Syringe Pump M500 by Shenzhen Comen Medical Instruments Co.,LTD.
- Infusion Pump EN-V7 by Shenzhen Enmind Technology Co., Ltd.
- EVO IQ ESYR002GRC by Baxter Healthcare SA
- ThermaCor 1200 Infusion System TIS-1200 by Smisson-Cartledge Biomedical, LLC
- nGEN Pump D139701 by Biosense Webster Inc